Strategic alliances have become increasingly important for pharmaceutical and biotech companies to fill pipelines, share risks and costs, and access new capabilities. The document discusses the shift toward more alliances and outsourcing in drug development. It also outlines best practices for forming alliances, including establishing governance committees and project teams to manage the collaboration. The role of alliance management is emphasized to build relationships, align objectives, and ensure alliances achieve their goals.
Related topics: